Literature DB >> 29338314

Inflammatory Cytokines in the Papillary Tips and Urine of Nephrolithiasis Patients.

Andrew Y Sun1, Bryan Hinck1, Benjamin R Cohen1, Karen Keslar2, Robert L Fairchild2, Manoj Monga1.   

Abstract

INTRODUCTION: Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients.
MATERIALS AND METHODS: Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression.
RESULTS: Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05).
CONCLUSION: Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.

Entities:  

Keywords:  biomarkers; gene expression; inflammation; nephrolithiasis; papillary tip

Mesh:

Substances:

Year:  2018        PMID: 29338314     DOI: 10.1089/end.2017.0699

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  Identifying risk factors for development of nephrolithiasis in end-stage renal disease patients.

Authors:  Charles Hesswani; Sameena Iqbal; Khashayar Rafat Zand; Simon Sun; Bernard Unikowsky; Caroline Reinhold; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

Review 2.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

3.  Quantitative proteomic analysis of urinary exosomes in kidney stone patients.

Authors:  Qing Wang; Yi Sun; Yuanyuan Yang; Cong Li; Jiaqiao Zhang; Shaogang Wang
Journal:  Transl Androl Urol       Date:  2020-08

4.  LncRNA HOXA11-AS regulates calcium oxalate crystal-induced renal inflammation via miR-124-3p/MCP-1.

Authors:  Yinhui Li; Guiling Yan; Jie Zhang; Wei Chen; Tao Ding; Yupeng Yin; Minghan Li; Yiqing Zhu; Shuhan Sun; Ji Hang Yuan; Zhiyong Guo
Journal:  J Cell Mol Med       Date:  2019-11-03       Impact factor: 5.310

5.  Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones.

Authors:  Yuqi Xia; Xiangjun Zhou; Zehua Ye; Weimin Yu; Jinzhuo Ning; Yuan Ruan; Run Yuan; Fangyou Lin; Peng Ye; Di Zheng; Ting Rao; Fan Cheng
Journal:  Front Genet       Date:  2021-12-06       Impact factor: 4.599

Review 6.  CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease.

Authors:  Ting-Ting Chang; Ching Chen; Jaw-Wen Chen
Journal:  Cardiovasc Diabetol       Date:  2022-09-15       Impact factor: 8.949

7.  Pyrrosia petiolosa Extract Ameliorates Ethylene Glycol-Induced Urolithiasis in Rats by Inhibiting Oxidative Stress and Inflammatory Response.

Authors:  Fangmin Zhou; Xingshan Wang
Journal:  Dis Markers       Date:  2022-08-05       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.